ESR1 and breast cancer: On the contrary, weakly metastatic breast cancer cells do not possess any functional VGSC due to the presence of ER, which may explain why the expression of Nav1.5 and nNav1.5 are higher in MDA-MB-231 as compared to MCF-7.